Cardiovascular benefits associated with some GLP-1 receptor agonists (semaglutide, dulaglutide, liraglutide) observed in clinical trials are likely to diminish after discontinuation, though the exact persistence of these benefits remains uncertain
doi:10.1007/s10495-025-02160-7 5
Find out what's happening in Across Connecticutfor free with the latest updates from Patch
Compounded medications from licensed 503A pharmacies undergo the same quality, sterility, and potency testing as brand products
Decrease dose if: Experiencing consistent side effects (headaches, fatigue, GI disturbance), achieving satisfactory results at current dose with no need for escalation, or cost considerations favor using minimum effective dose
Administration: Intramuscular injection by a qualified professional